Procalcitonin Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Procalcitonin Tests Market Report Overview
The procalcitonin tests market size was $557.2 million in 2023. Factors such as the surging burden of sepsis worldwide, rising public awareness, and increased use in antibiotic stewardship programs will drive the market growth at a CAGR of more than 1% during 2023-2033.
Procalcitonin (PCT) Tests are carried out to measure PCT production to diagnose and monitor sepsis. When sepsis occurs, primarily due to bacterial infection, PCT, a peptide precursor of the hormone calcitonin peptide, increases in response to a pro-inflammatory stimulus.
Procalcitonin Tests Market Outlook 2023-2033 ($ Million)
Buy the Full Report for More Insights on the Procalcitonin Tests Market Forecast,
Download a Free Sample Report
The procalcitonin tests market research report identifies quantitative market trends within drug delivery devices therapeutic areas. The report offers regional quantitative and qualitative data, highlighting the sales in major markets. The model also covers in detail the effects of COVID-19 on the procalcitonin tests market for 2020 and beyond. Furthermore, the report provides procalcitonin tests market share by company that will help in identifying untapped market opportunities.
Market Size (2023) | $557.2 million |
CAGR (2023-2033) | >1% |
Historic Period | 2015-2022 |
Forecast Period | 2023-2033 |
Key Segments | · Procalcitonin Enzyme Immunoassay Tests
· Procalcitonin Other Tests |
Key Regions | · Asia-Pacific
· Europe · Middle East and Africa · North America · South America |
Key Companies | · Thermo Fisher Scientific Inc
· F. Hoffmann-La Roche Ltd · bioMerieux SA · Bio-Rad Laboratories Inc · Beckman Coulter Inc + Radiometer Medical ApS |
Enquire & Decide | Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase. |
Procalcitonin Tests Market Segments
The key segments in the procalcitonin tests market are procalcitonin enzyme immunoassay tests and procalcitonin other tests. In 2023, the procalcitonin enzyme immunoassay tests segment dominated the market. The chemiluminescence enzyme immunoassay (CLEIA) is the predominant method employed for detecting procalcitonin (PCT) as an analyte in patient samples.
The chemiluminescence enzyme immunoassay (CLEIA) is the predominant method employed for detecting procalcitonin (PCT) as an analyte in patient samples. Procalcitonin in a patient sample is bound by separate antibodies, one for capture and one for indirect detection.
Procalcitonin Tests Market Analysis by Segments, 2023 (%)
Buy the Full Report for More Segment-Wise Insights into the Procalcitonin Tests Market
Download a Free Sample Report
Procalcitonin Tests Market Segmentation by Regions
The key regions in the procalcitonin tests market are Asia-Pacific, Europe, the Middle East and Africa, North America, and South America. In 2023, North America held the largest procalcitonin tests market share. The use of procalcitonin testing for sepsis management is highest in the US. This also serves as a major hub for sepsis-related clinical studies.
Compared to regions that accept CE mark in vitro diagnostics, the majority of the North American market lacks exposure to point-of-care PCT tests and testing platforms. Sufficient healthcare expenditure enables the use of automated immunoassay testing. Higher adoption of immunoassay platforms from high market share companies streamlines this process. The use of automated immunoassay testing decreases reliance on qualitative or semi-quantitative lateral flow assays. These assays are commonly used in other regions of the world.
Procalcitonin Tests Market Analysis by Regions, 2023 (%)
Buy the Full Report for more Regional Insights into the Procalcitonin Tests Market
Procalcitonin Tests Market – Competitive Landscape
In 2023, bioMerieux procalcitonin tests’ market share was the highest.
The major players in the procalcitonin tests market are:
- Thermo Fisher Scientific Inc.
- Hoffmann-La Roche Ltd
- bioMerieux SA
- Bio-Rad Laboratories Inc.
- Beckman Coulter Inc + Radiometer Medical ApS
Recent developments in PCT testing have often centered on the development and distribution of point-of-care tests and platforms, including devices aimed at ambulatory or field use.
Companies are adopting a comprehensive approach to sepsis management. This approach includes supporting PCT test sales with related products. For blood cultures, companies offer items as part of this approach. Molecular tests for pathogen detection are another component.
Procalcitonin Tests Market Analysis by Companies, 2023 (%)
Buy the Full Report for More Company-Wise Insights into the Procalcitonin Tests Market Companies
Download a Free Sample Report
Procalcitonin Tests Market Dynamics
Trends: The key factors positively impacting the procalcitonin tests market growth are the increasing burden of sepsis worldwide and rising public awareness. Also, the increased use of antibiotic stewardship programs will support market growth.
Future Outlook: PCT testing will find growth opportunities in low and middle-income countries wherein the burden of sepsis is highest. Point-of-care (POC) offerings including lateral flow immunoassays or mobile testing platforms may play a key role in driving further adoption of PCT testing for these growth markets.
Purchase the Complete Report for Additional Insights on the Procalcitonin Tests Market Dynamics,
Segments Covered in the Report
Procalcitonin Tests Segment Outlook (Value, $ Million, 2015-2033)
- Procalcitonin Enzyme Immunoassay Tests
- Procalcitonin Other Tests
Procalcitonin Tests Regional Outlook (Value, $ Million, 2015-2033)
- Asia-Pacific
- Europe
- Middle East and Africa
- North America
- South America
Key Inclusions
- The procalcitonin tests market research report includes an insightful review of the key industry trends.
- The procalcitonin tests market report offers an annualized market revenue by segment and market outlooks from 2015-2033.
- The report also includes market-level data on units, average selling prices, and market values.
Regional, Country, and Global Procalcitonin Tests Market Insights:
- The procalcitonin tests market share report offers qualitative insights on global and regional trends. In addition, GlobalData analysts provide unique country-specific insights on the market.
- Procalcitonin tests market SWOT analysis.
- The report provides trends and procalcitonin tests market competitive dynamics.
Buy the Full Report for More Insights on the Procalcitonin Tests Market Share,
Learn about consumer behavior through the detailed overview of segments and the healthcare system. The report also offers information on reimbursement policies and the regulatory landscape.
- Country-specific overview of the healthcare system.
- Country-specific reimbursement policies.
- Country-specific medtech regulatory landscape.
Robust methodologies and sources enable the model to provide an extensive and accurate overview of the market. These syndicated models include demand and supply-side primary sources including Key opinion leaders. In addition, determine market trends through real-world data sources including databases of government procedures and hospital purchasing.
Companies covered: Abbott Laboratories, Thermo Fisher Scientific Inc, Danaher Corp, F. Hoffmann-La Roche Ltd, DiaSorin SpA, bioMerieux SA, Bio-Rad Laboratories Inc, Siemens AG, Quidelortho Corp and Diazyme Laboratories Inc, and others.
Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina and Chile.
Scope
- Extensive coverage of the procalcitonin tests market under development.
- An exhaustive list of major pipeline products and their details, including product description, licensing and collaboration details, and other developmental activities.
- Reviews of major players involved in the development of the procalcitonin tests market and lists all their pipeline projects.
- Coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage.
- Key clinical trial data of ongoing clinical trials specific to pipeline products.
- Recent developments in the segment/industry.
Reasons to Buy
- Understand the COVID-19 impact on procalcitonin tests.
- Design your licensing strategies through a review of products, technologies, and companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving procalcitonin tests.
- Understand the trends, innovative product launches, technologies, segments, and companies that will impact the market in the future.
- Formulate effective sales and marketing strategies with a detailed evaluation of procalcitonin tests market share by company. Identify strong competitors and create winning strategies to stand out in the global procalcitonin tests market.
- Track regional procalcitonin tests market sales as well as country-specific transactions from 2015-2033.
- Organize your sales and marketing efforts by identifying the global procalcitonin tests market segments that present maximum opportunities. Such details will help to make investments and strategic partnerships.
Danaher Corp
F. Hoffmann-La Roche Ltd
DiaSorin SpA
bioMerieux SA
Siemens Healthineers AG
Quidelortho Corp
Diazyme Laboratories Inc
Thermo Fisher Scientific Inc
Bio-Rad Laboratories Inc and others.
Frequently asked questions
-
What was the procalcitonin tests market size in 2023?
The procalcitonin tests market size was $557.2 million in 2023.
-
What will the procalcitonin tests market growth rate be during the forecast period?
The procalcitonin tests market is expected to grow at a CAGR of more than 1% during 2023-2033.
-
Which is the leading segment in the procalcitonin tests market in 2023?
The procalcitonin enzyme immunoassay tests segment led the procalcitonin tests market in 2023.
-
Which region dominated the procalcitonin tests market in 2023?
North America had the largest regional segment of the procalcitonin tests market in 2023.
-
Which are the key companies operating in the procalcitonin tests market?
A few of the key companies in the procalcitonin tests market are Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd, bioMerieux SA, Bio-Rad Laboratories Inc., and Beckman Coulter Inc. + Radiometer Medical ApS, among others.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.